Assist. Prof. Dr. Ting Zhu | Pharmaco-Oncology | Best Researcher Award

Assist. Prof. Dr. Ting Zhu | Pharmaco-Oncology | Best Researcher Award

Qingdao University | China

AUTHOR PROFILE

Scopus

ORCID ID

🧩 EARLY ACADEMIC PURSUITS

Dr. Ting Zhu’s academic journey began with a strong foundation in pharmacology and related biomedical sciences. Her early education and research laid the groundwork for her focus on cardiovascular and cerebrovascular pharmacology. This formative phase shaped her expertise in the integration of traditional Chinese medicine (TCM) with modern pharmacological principles.

💼 PROFESSIONAL ENDEAVORS

As a Master’s Supervisor at Qingdao Medical College, Qingdao University, Dr. Zhu has become a pivotal figure in guiding students and contributing to cutting-edge research. Her dedication to academic excellence is reflected in her active leadership in national and provincial projects, fostering innovation and exploration in pharmacological sciences.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACO-ONCOLOGY

Dr. Zhu’s research delves into the regulation of mitochondria by TCM and its main components for the prevention and treatment of nerve injury. Her groundbreaking work has revealed the preventive effects and molecular mechanisms of these compounds on ischemic stroke, bridging traditional medicine with modern therapeutic approaches.

🌟 IMPACT AND INFLUENCE

Dr. Zhu’s research outputs, including more than 20 academic papers published in high-level international journals, have significantly advanced the understanding of ischemic stroke and pharmacological neuroprotection. Her work has gained recognition within the academic community for its innovation and practical applications.

📖 ACADEMIC CITATIONS

With a robust publication record, Dr. Zhu’s studies have garnered extensive citations in the global scientific community, reflecting the influence and relevance of her research. Her findings continue to inform and inspire further investigations in pharmacology and TCM integration.

🎯 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Zhu’s ongoing dedication to exploring molecular mechanisms and drug development promises a lasting impact on the field of pharmacology. Her leadership in bridging traditional and modern medicinal practices positions her as a key figure in shaping future therapeutic strategies for nerve injury and cardiovascular diseases.

🏅 OTHER SIGNIFICANT ACHIEVEMENTS

  • National and Provincial Projects: Successfully presided over three major scientific research initiatives.
  • Mentorship: Plays a crucial role in cultivating the next generation of researchers in pharmacology and TCM.
  • Cross-disciplinary Innovation: Pioneering efforts in integrating mitochondrial regulation with TCM for innovative therapeutic approaches.

Dr. Ting Zhu’s remarkable contributions underscore her commitment to advancing science and medicine through an interdisciplinary lens, promising a transformative impact on global healthcare.

🔗 CONCLUSION

Dr. Ting Zhu stands at the forefront of modern pharmacology, seamlessly integrating traditional Chinese medicine with advanced molecular research to address pressing health challenges like ischemic stroke and nerve injury. Her dedication to mentorship, impactful research, and innovative drug development underscores her significant contributions to both academic and clinical fields. As she continues to lead groundbreaking projects and inspire future generations, Dr. Zhu’s work promises to shape the future of pharmacology and redefine the role of traditional medicine in modern therapeutic practices. Her legacy is one of innovation, excellence, and transformative impact on global health.

 

📊🔬NOTABLE PUBLICATION:
  • Pharmacological Properties and Mechanisms of Notoginsenoside R1 in Ischemia-Reperfusion Injury
    • Authors: Zhu, T., Wan, Q.
    • Journal: Chinese Journal of Traumatology – English Edition
    • Year: 2023

 

  • Notoginseng Leaf Triterpenes Ameliorates Mitochondrial Oxidative Injury via the NAMPT-SIRT1/2/3 Signaling Pathways in Cerebral Ischemic Model Rats
    • Authors: Xie, W., Zhu, T., Zhou, P., Sun, G., Sun, X.
    • Journal: Journal of Ginseng Research
    • Year: 2023

 

  • DL-3-n-Butylphthalide Attenuates Cerebral Ischemia/Reperfusion Injury in Mice Through AMPK-Mediated Mitochondrial Fusion
    • Authors: Zhu, T., Dong, S., Qin, N., Shi, L., Wan, Q.
    • Journal: Frontiers in Pharmacology
    • Year: 2024

 

  • Effect of Salidroside on Neuroprotection and Psychiatric Sequelae During the COVID-19 Pandemic: A Review
    • Authors: Zhu, T., Liu, H., Gao, S., Chen, S., Xie, W.
    • Journal: Biomedicine and Pharmacotherapy
    • Year: 2024

 

  • Mechanism of Efferocytosis in Determining Ischemic Stroke Resolution—Diving into Microglia/Macrophage Functions and Therapeutic Modality
    • Authors: Xie, X.-D., Dong, S.-S., Liu, R.-J., Shi, L.-L., Zhu, T.
    • Journal: Molecular Neurobiology
    • Year: 2024

Mrs. Jelena Kovacic | New Drug Development | Best Researcher Award

Mrs. Jelena Kovacic | New Drug Development | Best Researcher Award

Faculty of Pharmacy and Biochemistry University of Zagreb | Croatia

Author Profile 

Scopus

ORCID ID

Google Scholar

🎓EARLY ACADEMIC PURSUITS 

Jelena Kovačić embarked on her academic journey with a Master of Science in Applied Chemistry from the Faculty of Chemical Engineering and Technology in Zagreb, completed in 2021. Her master’s thesis focused on the monitoring of degradation of selected active substances, laying a solid foundation for her research career.

🔬PROFESSIONAL ENDEAVORS 

Jelena is currently a Ph.D. researcher at the Faculty of Pharmacy and Biochemistry, University of Zagreb. Her work primarily involves developing advanced analytical methods for drugs and biologically active substances, specifically targeting treatments for inflammatory bowel disease. Her role also includes involvement in stability-indicative methods, compatibility studies, and therapeutic drug monitoring.

🧪CONTRIBUTIONS AND RESEARCH FOCUS ON NEW DRUG DEVELOPMENT

Jelena’s research contributions are centered around preformulation studies, including forced degradation studies and compatibility assessments. She is also engaged in bioanalytical research, focusing on therapeutic drug monitoring and microextraction techniques. Her work involves advanced analytical techniques such as liquid chromatography (LC), mass spectrometry (MS), and chemometrics.

🌟IMPACT AND INFLUENCE 

Through her active participation in international symposia and congresses, Jelena has contributed to the broader scientific community’s understanding of analytical methods and bioanalytical techniques. Her research aims to enhance the efficacy and safety of drug treatments, particularly in the context of inflammatory bowel diseases.

📚ACADEMIC CITATIONS 

Jelena has established a growing presence in the academic community with her research contributions and presentations at various international platforms. Her work is expected to garner more citations as she progresses in her doctoral studies and publishes her findings.

🔮LEGACY AND FUTURE CONTRIBUTIONS 

Jelena Kovačić’s future contributions are anticipated to make a significant impact on the field of pharmaceutical sciences. With her expertise in developing advanced analytical methods and her dedication to research in drug treatments, she is poised to advance the understanding and application of these methods in clinical settings, thereby shaping future research and development in the field.

🎯Conclusion

Jelena Kovačić is an emerging researcher with a strong foundation in applied chemistry and a promising trajectory in pharmaceutical sciences. Her academic pursuits and professional experiences reflect a deep commitment to advancing analytical methods and bioanalytical techniques, particularly in the treatment of inflammatory bowel disease. Through her work, she contributes valuable insights into drug development and stability, enhancing the field’s overall knowledge and application. Her active participation in international forums and her ongoing research efforts position her as a future leader in pharmaceutical research, with the potential to significantly influence drug treatment methodologies and improve patient outcomes. As she continues to develop her expertise, Jelena is set to leave a lasting impact on the scientific community

📊🔬NOTABLE PUBLICATION:

 

  • Polyphenol content and antioxidant activity of phytoestrogen containing food and dietary supplements: DPPH free radical scavenging activity by HPLC
    • Authors: Klarić, D.A., Mornar, A., Kovačić, J., Brletić, I., Klarić, I.
    • Journal: Acta Pharmaceutica
    • Year: 2022

 

  • Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease
    • Authors: Jeličić, M.-L., Amidžić Klarić, D., Kovačić, J., Verbanac, D., Mornar, A.
    • Journal: Pharmaceuticals
    • Year: 2022

 

  • Green Solid-Phase (Micro)Extraction of Andrographolides from Human Plasma Samples Followed by UHPLC-DAD-QqQ-MS/MS Analysis
    • Authors: Kovačić, J., Jeličić, M.-L., Amidžić Klarić, D., Mornar, A.
    • Journal: Separations
    • Year: 2023

 

  • Antioxidant Activity of Pharmaceuticals: Predictive QSAR Modeling for Potential Therapeutic Strategy
    • Authors: Jeličić, M.-L., Kovačić, J., Cvetnić, M., Mornar, A., Klarić, D.A.
    • Journal: Pharmaceuticals
    • Year: 2022

 

  • Size exclusion chromatography as green support for forced degradation study of adalimumab
    • Authors: Kovačić, J., Klarić, D.A., Turk, N., Mornar, A.
    • Journal: Acta Pharmaceutica
    • Year: 2023